The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Detrusitol SR 2 mg, prolonged-release capsules, hard

2 milligram(s) Prolonged-release capsule

Pfizer Healthcare IrelandPA0822/125/001

Main Information

Trade NameDetrusitol SR 2 mg, prolonged-release capsules, hard
Active SubstancesTolterodine l-tartrate
Strength2 milligram(s)
Dosage FormProlonged-release capsule
Licence HolderPfizer Healthcare Ireland
Licence NumberPA0822/125/001

Group Information

ATC CodeG04BD Drugs for urinary frequency and incontinence
G04BD07 tolterodine

Status

Authorised/WithdrawnAuthorised
Licence Issued27/07/2001
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0025-006-032
Interchangeable List DocumentPDF of Interchangeable List
« Back